A synthetic DNA vaccine candidate for Middle East respiratory syndrome coronavirus (MERS-CoV) induced potent immune responses and afforded protective efficacy in non-human primate models when given intradermally in abbreviated, low-dose immunization regimen.
from Latest Science News -- ScienceDaily https://ift.tt/3tOAi47
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment